by Eric Christianson | Apr 29, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Clonidine and guanfacine are both alpha-2 adrenergic agonists used in the treatment of ADHD, but they behave differently enough in clinical practice that they are not truly interchangeable. In this article, we will compare and contrast clonidine versus guanfacine in...
by Eric Christianson | Dec 10, 2023 | Pediatrics Medication and Disease State Clinical Pearls, Psychiatry and Addiction Medication and Disease State Clinical Pearls
This article will discuss two of the three commonly used non-stimulant medications for the management of ADHD and ADHD-related symptoms. We will primarily focus on comparing clonidine versus guanfacine in pediatric patients. As pharmacies deal with shortages of more...
by Eric Christianson | Nov 26, 2023 | Polypharmacy Cases And The Prescribing Cascade
In this case, I outline a unique situation involving stimulants and elderly patients. I outline some of the potential complications and contributions to the prescribing cascade. A 76-year-old female resides in an assisted living. She has a history of ADHD, anxiety,...
by Eric Christianson | Feb 8, 2023 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Attention Deficit Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children, occurring almost twice as often in boys compared to girls. The most observed symptoms are inattention, hyperactivity, and impulsivity, but the primary...
by Eric Christianson | Aug 10, 2022 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
If you are anything like me, it is difficult to keep up with everything. ADHD is one of those areas that I don’t help with very frequently from a clinical standpoint. I love useful resources when I find them. Dosage forms are a particular weakness in my ADHD...
